This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.
Automatically generated on February 8, 2020.
Return to the list of Patented Medicine Litigation page.
- 1314876: COBALT, APOTEX
- 2148071: NOVOPHARM, COBALT, RHOXALPHARMA, APOTEX,
- PM(NOC) – T-2375-00
- Section 8 – T-825-06 (2013 FC 493)
- Appeal – A-208-13 (2014 FCA 54) – A-225-15
- PM(NOC) – T-1937-03 (2005 FC 1421)
- PM(NOC) – T-530-04
- PM(NOC) – A-499-05
- PM(NOC) – T-342-04
Return to the Patented Medicine Litigation page.